Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Amarin advances phase III AMR-101 trials in patients with high trigliceride levels

Aug. 10, 2010

Repros receives positive feedback on Androxal from FDA

Aug. 10, 2010

Daiichi Sankyo presents new agents for treatment of osteoporosis

Aug. 10, 2010

FDA to complete review of lorcaserin NDA in October

Aug. 9, 2010

Elder Pharmaceuticals discovers new glucose-lowering agents

Aug. 9, 2010

BPR-0912 exhibits antiobesity effects in vivo

Aug. 9, 2010

Takeda presents new glucokinase activators

Aug. 6, 2010

Preclinical study implicates GPR55 in regulation of osteoclast number and function

Aug. 6, 2010

CANOE trial data support use of Avandamet to prevent type 2 diabetes

Aug. 6, 2010

New FPS inhibitors discovered at Novartis

Aug. 6, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...